⌘K

Home/Filings/4/0001209191-17-002628

4//SEC Filing

FATE THERAPEUTICS INC 4

Accession 0001209191-17-002628

$FATECIK 0001434316operating

View on SEC.gov Company Profile

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:02 PM ET

Size

5.5 KB

Accession

0001209191-17-002628

Insider Transaction Report

Form 4

Period: 2017-01-04

FATE THERAPEUTICS INCFATE

Chief Development Officer

Transactions

Award
Stock Option (right to buy)
2017-01-04+150,000→ 150,000 total
Exercise: $2.73Exp: 2027-01-03→ Common Stock (150,000 underlying)

Footnotes (2)

[F1]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 4, 2017 such that this option is fully exercisable on January 4, 2021.
[F2]Not applicable.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

FATE THERAPEUTICS INC

CIK 0001434316

Entity typeoperating

Related Parties

1

filerCIK 0001434316

Filing Metadata

Form type: 4
Filed: Jan 5, 7:00 PM ET
Accepted: Jan 6, 4:02 PM ET
Size: 5.5 KB

View on SEC.gov